ANGIOLOGY血管学
ANGIOLOGY(英文缩写 ANGIOLOGY),ISSN 0003-3197,eISSN 1940-1574,中文译名:血管学 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。
发文量统计区间：2025-09-28 至 2026-09-28，按本站收录文献的发表日期统计。
期刊介绍
历年影响因子趋势
| JCR 数据年份 | 影响因子 | JCR 分区 |
|---|---|---|
| 2021 | 3.299 | Q3 |
| 2022 | 2.800 | Q3 |
| 2023 | 2.600 | Q2 |
| 2024 | 2.200 | Q3 |
| 2025 | 2.700 | Q2 |
ANGIOLOGY 最新收录文献
-
1. Letter: Comment on: Uric Acid/Albumin Ratio and Carotid Atherosclerosis.
PMID:日期:2026-10-01该文献暂无摘要。
-
3. Letter: NLRC5 and NF-κB Signaling: Implications for Atherosclerotic Plaque Formation in Acute Coronary Syndromes.
PMID:日期:2026-10-01该文献暂无摘要。
-
4. Letter: Endothelial Health in Carotid Stenting: Bridging Inflammation and Activation With CAR and EASIX.
PMID:日期:2026-10-01该文献暂无摘要。
-
5. Letter: Remnant Cholesterol and No-Reflow in STEMI: Considerations on Endpoint Definition, Confounding, and Validation.
PMID:日期:2026-10-01该文献暂无摘要。
-
7. Letter: SIRI Facilitates Risk Stratification and Prognostication in Coronary Artery Disease.
PMID:日期:2026-10-01该文献暂无摘要。
-
8. Letter: Elevated Uric Acid/Albumin Ratio as a Predictor of Carotid Plaque in Patients With Coronary Artery Disease.
PMID:日期:2026-10-01该文献暂无摘要。
-
9. Letter: Inflammatory Markers to Predict Carotid Artery Plaque in Patients With Coronary Artery Disease.
PMID:日期:2026-10-01该文献暂无摘要。
-
10. Remnant Cholesterol as a Predictor of No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction.
PMID:日期:2026-10-01Remnant cholesterol (RC) has been implicated in the progression of atherosclerotic cardiovascular disease. However, the impact of RC levels on the occurrence of no-reflow in patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention (pPCI) remains poorly understood. Patients were classified into 2 groups: those (n = 90) who developed no-reflow (+) and those (n = 350) who did not develop no-reflow (-). RC was calculated as total cholesterol minus low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C). RC (Odds Ratio [OR] = 1.28, < .001), diabetes mellitus (OR = 2.72, = .002), stent length (OR = 1.07, = .020), door-to-balloon time (OR = 1.04, = .047), symptom-to-admission time (OR = 2.07, = .002) and presence of thrombus (OR = 2.34, < 0.001) were independent predictors of no-reflow. RC was shown to predict no-reflow development (Area under the curve [AUC] = 0.923, < .001). The present study revealed a significant association between RC levels and the occurrence of the no-reflow phenomenon following pPCI in patients with STEMI. Assessment of RC levels may assist in identifying high-risk groups in STEMI patients and may prove to be an important factor to manage for cardiovascular health.